Financials
- Market Capitalization 7.96 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-8.97
Índice preço/fluxo de caixa
—
Related tickers
| # | Nome | Preços | 24h % | 7d % | 1M % | 1A % | Capitalização de mercado | Últimos 7 dias | |
|---|---|---|---|---|---|---|---|---|---|
| 1018 | APGE Apogee Therapeutics, Inc. - Common Stock | 133.96 USD | +0.10% | +0.28% | +49.41% | +149.97% | 8.29 B USD | ||
| 1030 | PCVX Vaxcyte, Inc. - Common Stock | 56.20 USD | -1.46% | -7.37% | +17.80% | +32.86% | 8.12 B USD | ||
| 1048 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 62.01 USD | +1.76% | -7.85% | +19.83% | +56.41% | 7.75 B USD | ||
| 1075 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 109.83 USD | +2.18% | -4.05% | +18.10% | -0.44% | 7.53 B USD |